multidrug resistance
54 projects
H2020Individual fellowship2017–2019Netherlands
MDRZYMES · Multidrug resistance gene regulators as scaffolds for the design and evolution of artificial metalloenzymes
H2020Individual fellowship2017–2019United Kingdom
NinZA · Theranostic molecular zipper based switchable nanomedicine for overcoming drug resistance
H2020Doctoral network2017–2020Italy
Train2Target · An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries
17 partners · 8 countries
H2020COFUND2016–2021Netherlands
ALERT · Local Training Network on Novel Tailor-Made Antimicrobials and Delivery Strategies From Synthesis towards Clinical Applications
H2020Individual fellowship2016–2018United Kingdom
KILLINGTYPHI · Identification of host-factors restricting Salmonella Typhi
H2020Staff exchange2016–2019France
PANG · Pathogen and Graphene
8 partners · 6 countries
H2020Individual fellowship2016–2018United Kingdom
T6SS-PSEUDO-LIP · Type VI-dependent Pseudomonas aeruginosa phospholipases and host manipulation
H2020Individual fellowship2016–2018Netherlands
Inflammafish · Cross-talk between inflammation and autophagy in tuberculosis
H2020Individual fellowship2015–2017United Kingdom
NOVENA · Exploiting an unusual polyketide chain release mechanism for production of novel enacyloxin antibiotic analogues
H2020Individual fellowship2015–2017France
MDR Tuberculosis · Evolution and success of the multi-drug resistant M. tuberculosis SIT41 (LAM7-TUR) lineage
H2020Individual fellowship2015–2017Netherlands
AND · Antibacterial (Nano)medicines Development
H2020Individual fellowship2015–2017Netherlands
PneumoCompetence · Unravelling the mechanisms of competence induction by antibiotic stress in Streptococcus pneumoniae
H2020Individual fellowship2015–2017Spain
InterAcTEV · Genome-wide analysis of RNA and protein interacting profiles during a plant virus infection
FP7Staff exchange2013–2017Sweden
TB PROGNOSIS · A progress of tuberculosis and HIV/tuberculosis treatment assessed by fingerprinting of small molecule-biomarkers in patients from Eastern Europe
2 partners · 2 countries
FP7Reintegration grant2011–2015Spain
Neuroblastoma Chemo · Chemotherapy of neuroblastoma
FP7Individual fellowship2011–2013Netherlands
TB host genes · TB host genes
FP7Individual fellowship2010–2012Portugal
ECOCHAR · Characterization of widespread uropathogenic multidrug resistant Escherichia coli clones by using a combined approach of conventional genotypic methods and high-throughput technology
FP7Reintegration grant2009–2013Israel
IMMUNITY TO LISTERIA · Mechanisms of innate immune activation of the intracellular bacterial pathogen L. monocytogenes
FP6Individual fellowship2008–2009France
MODERN TB DETECTION · Multidrug-resistant and hypervirulent tuberculosis: integral approach to rapid detection and evolution
FP6Reintegration grant2007–2009Hungary
PHARMACOGENOMICS · Targeting multidrug resistant cancer
FP6Individual fellowship2007–2008Hungary
ABC TRANSPORTERS · Implementation of a pharmacogenomic approach to predict ABC transporter substrates and compounds selectively targeting multidrug resistant cancer
FP6Reintegration grant2005–2007Hungary
SZAKONYI · Structural and functional studies of different bacterial multi-drug resistance proteins of DMT and MOP super-families
FP6Individual fellowship2005–2007United Kingdom
CSOBMTS · Crystallographic studies of bacterial membrane transport systems
FP6Reintegration grant2005–2005Spain